139 related articles for article (PubMed ID: 37812599)
1. The HPV-TP53-MALAT1 Axis: Unravelling interactions in cervical cancer development.
Iordanishvili S; Metreveli T; Lipartia E; Gachechiladze K; Khuntsaria I; Qobulashvili T; Jorbenadze M; Revazishvili T; Kldiashvili E; Kaufmann AM
PLoS One; 2023; 18(10):e0291725. PubMed ID: 37812599
[TBL] [Abstract][Full Text] [Related]
2. MALAT1-miR-124-RBG2 axis is involved in growth and invasion of HR-HPV-positive cervical cancer cells.
Liu S; Song L; Zeng S; Zhang L
Tumour Biol; 2016 Jan; 37(1):633-40. PubMed ID: 26242259
[TBL] [Abstract][Full Text] [Related]
3. The involvement of MALAT1-ALKBH5 signaling axis into proliferation and metastasis of human papillomavirus-positive cervical cancer.
Wu S; Liu L; Xu H; Zhu Q; Tan M
Cancer Biol Ther; 2023 Dec; 24(1):2249174. PubMed ID: 37639643
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA MALAT1 modulates radiosensitivity of HR-HPV+ cervical cancer via sponging miR-145.
Lu H; He Y; Lin L; Qi Z; Ma L; Li L; Su Y
Tumour Biol; 2016 Feb; 37(2):1683-91. PubMed ID: 26311052
[TBL] [Abstract][Full Text] [Related]
5. Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence.
Alsbeih GA; Al-Harbi NM; Bin Judia SS; Khoja HA; Shoukri MM; Tulbah AM
Cancer; 2017 Jul; 123(13):2459-2466. PubMed ID: 28393355
[TBL] [Abstract][Full Text] [Related]
6. Expression of the Long Noncoding RNA DINO in Human Papillomavirus-Positive Cervical Cancer Cells Reactivates the Dormant TP53 Tumor Suppressor through ATM/CHK2 Signaling.
Sharma S; Munger K
mBio; 2020 Jun; 11(3):. PubMed ID: 32546626
[TBL] [Abstract][Full Text] [Related]
7. TP53 polymorphism, HPV infection, and risk of cervical cancer.
Klug SJ; Wilmotte R; Santos C; Almonte M; Herrero R; Guerrero I; Caceres E; Peixoto-Guimaraes D; Lenoir G; Hainaut P; Walboomers JM; Muñoz N
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):1009-12. PubMed ID: 11535556
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism in exon 4 of TP53 gene associated to HPV 16 and 18 in Mexican women with cervical cancer.
Piña-Sánchez P; Hernández-Hernández DM; Taja-Chayeb L; Cerda-Flores RM; González-Herrera AL; Rodea-Avila C; Apresa-García T; Ostrosky-Wegman P; Vázquez-Ortíz G; Mendoza-Lorenzo P; Dueñas-González A; Salcedo M
Med Oncol; 2011 Dec; 28(4):1507-13. PubMed ID: 20661667
[TBL] [Abstract][Full Text] [Related]
9. Association Between MALAT1 and THRIL Polymorphisms and Precancerous Cervical Lesions.
Wang Y; Liu Y; Li Z; Yan X; Huang C; Ye X; Sun X; Qin S; Zhong X; Zeng C; Liu D; Zou X; Liu Y; Wu J; Wen Z; Yang G; Jing C; Wei X
Genet Test Mol Biomarkers; 2018 Sep; 22(9):509-517. PubMed ID: 30188187
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1.
Liu H; Xu J; Yang Y; Wang X; Wu E; Majerciak V; Zhang T; Steenbergen RDM; Wang HK; Banerjee NS; Li Y; Lu W; Meyers C; Zhu J; Xie X; Chow LT; Zheng ZM
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33436409
[TBL] [Abstract][Full Text] [Related]
11. p53 Arg72Pro polymorphism, HPV status and initiation, progression, and development of cervical cancer: a systematic review and meta-analysis.
Habbous S; Pang V; Eng L; Xu W; Kurtz G; Liu FF; Mackay H; Amir E; Liu G
Clin Cancer Res; 2012 Dec; 18(23):6407-15. PubMed ID: 23065429
[TBL] [Abstract][Full Text] [Related]
12. ТР53 Codon 72 Polymorphism and Human Papilloma Virus-Associated Cervical Cancer in Kyrgyz Women.
Isakova J; Vinnikov D; Bukuev N; Talaibekova E; Aldasheva N
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1057-1062. PubMed ID: 31030474
[TBL] [Abstract][Full Text] [Related]
13. TP53 codon 72 polymorphism does not affect risk of cervical cancer in patients from The Gambia.
Tanara G; Falugi C; Cesario A; Margaritora S; Russo P; Cosimi A
Int J Biol Markers; 2003; 18(4):280-3. PubMed ID: 14756543
[TBL] [Abstract][Full Text] [Related]
14. P53 codon 72 polymorphism, human papillomavirus infection, and their interaction to oral carcinoma susceptibility.
Hou J; Gu Y; Hou W; Wu S; Lou Y; Yang W; Zhu L; Hu Y; Sun M; Xue H
BMC Genet; 2015 Jun; 16():72. PubMed ID: 26123760
[TBL] [Abstract][Full Text] [Related]
15. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.
Yuan F; Sun R; Chen P; Liang Y; Ni S; Quan Y; Huang J; Zhang L; Gao L
Tumour Biol; 2016 May; 37(5):6267-73. PubMed ID: 26619844
[TBL] [Abstract][Full Text] [Related]
16. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value.
Cho NH; Lim SY; Kim YT; Kim D; Kim YS; Kim JW
Gynecol Oncol; 2003 Jul; 90(1):15-22. PubMed ID: 12821336
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas.
Helland A; Holm R; Kristensen G; Kaern J; Karlsen F; Trope C; Nesland JM; Børresen AL
J Pathol; 1993 Oct; 171(2):105-14. PubMed ID: 8283348
[TBL] [Abstract][Full Text] [Related]
18. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between p53 Arg72Pro polymorphism and cervical carcinoma in Uigur and Han women in Xinjiang].
Zheng XZ; Yang AQ; Pan XL; Zheng LL; Zhou QY; Li XM; Wang XL; Yan LH; Li HA
Zhonghua Bing Li Xue Za Zhi; 2007 Aug; 36(8):511-5. PubMed ID: 17980096
[TBL] [Abstract][Full Text] [Related]
20. Uncommon non-oncogenic HPV genotypes, TP53 and MDM2 genes polymorphisms in HIV-infected women in Southern Brazil.
Entiauspe LG; Seixas FK; Nunes EM; Rodrigues FM; Dellagostin OA; Collares T; da Silveira MF
Braz J Infect Dis; 2014; 18(6):643-50. PubMed ID: 25181402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
